Comments on: R&D Costs, Innovative Output, and Firm Size in the Pharmaceutical Industry

1995 ◽  
Vol 2 (2) ◽  
pp. 221-222
Author(s):  
PAUL W. Macavoy
Keyword(s):  
Pharmaceutical Industry ◽  
Firm Size ◽  
Innovative Output

R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry

1995 ◽  
Vol 2 (2) ◽  
pp. 201-219 ◽  
Author(s):  
Joseph A. Dimasi ◽  
Henry G. Grabowski ◽  
John Vernon
Keyword(s):  
Pharmaceutical Industry ◽  
Firm Size ◽  
Innovative Output

scholarly journals R&D Efficiency and Firm Size in the Japanese Pharmaceutical Industry

2007 ◽  
Vol 17 (2) ◽  
pp. 195-206
Author(s):  
Qin-Chang Zhang ◽  
Yuji Honjo
Keyword(s):  
Pharmaceutical Industry ◽  
Firm Size

scholarly journals Assessing Impact of Liberalization on Financial Performance Sustainability of Indian Pharmaceutical Industry using Structure Conduct Performance Model

2021 ◽  
Vol 12 (3) ◽  
pp. 3085-3091
Author(s):  
Dr. Pankaj Talreja Et.al
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Performance ◽  
Market Structure ◽  
Firm Size ◽  
Performance Model ◽  
Raw Material ◽  
Direct Impact ◽  
Pharmaceutical Firms ◽  
Immense Potential ◽  
Indian Pharmaceutical Industry

The Indian Pharmaceutical Industry is ranked third largest by volume and fourteenth by value. It thus accounts for 10% of world’s production by volume and 1.5% by value according to Department of Pharmaceuticals, Government of India. Recognizing the immense potential for growth of Indian pharmaceutical industry and its direct impact on Indian economy the present paper tries to analyze the market structure of the Indian pharmaceutical firms and assess how the sustainable profitability of firms is affected using structure conduct performance model. The study founds out the sustainable profitability is statistically related to firm size, export and import, raw material expenses, power use and wage intensity but there seems to be insignificant effect of market share and mergers and acquisition on firm’s performance in terms of sustainable profitability.

scholarly journals Technical Change and Firm Size: The Pharmaceutical Industry

1974 ◽  
Vol 56 (3) ◽  
pp. 294 ◽  
Author(s):  
John M. Vernon ◽  
Peter Gusen
Keyword(s):  
Pharmaceutical Industry ◽  
Firm Size ◽  
Technical Change

scholarly journals Factors Affecting Value of Companies (Case Study of The Indonesian Pharmaceutical Industry)

2021 ◽  
Vol 3 (2) ◽  
pp. 23
Author(s):  
Harmaini Harmaini
Keyword(s):  
Data Analysis ◽  
Pharmaceutical Industry ◽  
Firm Size ◽  
Firm Value ◽  
Stock Exchange ◽  
Panel Data Analysis ◽  
Analysis Method ◽  
Cross Sectional ◽  
Factors Affecting ◽  
Data Analysis Method

The pharmaceutical industry in Indonesia has good prospects in the future. With the outbreak of Covid 19, the pharmaceutical industry is increasingly important. Firm value reflects the ability of a company to return investment so as to convince investors to invest in the company. It leads us into question what has an impact on firm value. This study aims to determine and analyze the effect of firm size, solvency, and profitability on company assessment either simultaneously or partially. The population in this study were pharmaceutical companies listed on the Indonesia Stock Exchange for the period 2013 to 2018. The sample in this study was selected using a purposive sampling method which selected 7 companies from 12 companies that would be used as research objects. The data analysis method used is the panel data analysis method or a combination of cross sectional and time series. The research results obtained are simultaneously firm size, solvency, and profitability have an effect on firm value. Meanwhile, partially solvency and profitability have an effect on firm value. However, company size has no effect on firm value.

scholarly journals Microfirms and innovation in the service sector

2020 ◽  
Vol 55 (4) ◽  
pp. 997-1018
Author(s):  
David B. Audretsch ◽  
Alexander S. Kritikos ◽  
Alexander Schiersch
Keyword(s):  
Labor Productivity ◽  
Firm Size ◽  
Service Sector ◽  
Structural Models ◽  
Innovation Activities ◽  
Start Up ◽  
Innovation Output ◽  
Knowledge Intensive ◽  
Start Ups ◽  
Innovative Output

Abstract In the context of microfirms, this paper analyzes whether the link between the three aspects involving innovative activities—R&D, innovative output, and productivity—hold for knowledge-intensive services. With especially high start-up rates and the majority of employees in microfirms, knowledge-intensive services (KIS) have a starkly different profile from manufacturing. Results from our structural models indicate that KIS firms benefit from innovation activities through increased labor productivity with highly skilled employees being similarly important compared to R&D for creating innovation output in microfirms. Moreover, the firm size advantage of large firms found for manufacturing almost disappears in KIS, with start-ups and young firms having a higher probability of initiating innovation activities and of successfully turning knowledge into innovation output than mature firms.

Sign in / Sign up

Export Citation Format

Share Document